Cargando…
Management options for stage 1 nonseminomatous germ cell tumors of the testis
Management of clinical stage I non seminomatous germ cell tumor includes surveillance, primary chemotherapy and retroperitoneal lymph node dissection. Stratifying clinical stage I disease to high-and low-risk groups for harboring micrometastic retroperitoneal disease (pathologic stage B) is based on...
Autor principal: | Beck, Stephen D. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878443/ https://www.ncbi.nlm.nih.gov/pubmed/20535290 http://dx.doi.org/10.4103/0970-1591.60455 |
Ejemplares similares
-
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: Current concepts and controversies
por: Jayram, Gautam, et al.
Publicado: (2010) -
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
por: Fitzgerald, John P., et al.
Publicado: (2010) -
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: Clinical significance and management options
por: Risk, Michael C., et al.
Publicado: (2010) -
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
por: Bilen, Mehmet Asim, et al.
Publicado: (2016) -
Incidental detection of Zinner syndrome in a patient with nonseminomatous germ cell tumor of testis
por: Khoda, Jeevitesh, et al.
Publicado: (2020)